123 related articles for article (PubMed ID: 7682952)
1. Differentiation antigens of human germ cell tumours: distribution of carbohydrate epitopes on glycolipids and glycoproteins analyzed using PDMP, an inhibitor of glycolipid synthesis.
Fenderson BA; Radin N; Andrews PW
Eur Urol; 1993; 23(1):30-6; discussion 36-7. PubMed ID: 7682952
[TBL] [Abstract][Full Text] [Related]
2. A ceramide analogue (PDMP) inhibits glycolipid synthesis in fish embryos.
Fenderson BA; Ostrander GK; Hausken Z; Radin NS; Hakomori S
Exp Cell Res; 1992 Feb; 198(2):362-6. PubMed ID: 1729139
[TBL] [Abstract][Full Text] [Related]
3. Glycolipid depletion using a ceramide analogue (PDMP) alters growth, adhesion, and membrane lipid organization in human A431 cells.
Barbour S; Edidin M; Felding-Habermann B; Taylor-Norton J; Radin NS; Fenderson BA
J Cell Physiol; 1992 Mar; 150(3):610-9. PubMed ID: 1537889
[TBL] [Abstract][Full Text] [Related]
4. Effects of D-threo-PDMP, an inhibitor of glucosylceramide synthetase, on expression of cell surface glycolipid antigen and binding to adhesive proteins by B16 melanoma cells.
Inokuchi J; Momosaki K; Shimeno H; Nagamatsu A; Radin NS
J Cell Physiol; 1989 Dec; 141(3):573-83. PubMed ID: 2531751
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of glycolipid biosynthesis inhibitors on ceramide-induced cell death in neuroblastoma cells.
Bieberich E; Freischütz B; Suzuki M; Yu RK
J Neurochem; 1999 Mar; 72(3):1040-9. PubMed ID: 10037475
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical and biochemical characterisation of the expression of a human embryonal carcinoma cell proteoglycan antigen in human germ cell tumours and other tissues.
Mason MD; Pera MF
Eur J Cancer; 1992; 28A(6-7):1090-8. PubMed ID: 1320911
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of cell surface antigens expressed by cell lines derived from human germ cell tumours.
Andrews PW; Casper J; Damjanov I; Duggan-Keen M; Giwercman A; Hata J; von Keitz A; Looijenga LH; Millán JL; Oosterhuis JW; Pera M; Sawada M; Schmoll HJ; Skakkebaek NE; van Putten W; Stern P
Int J Cancer; 1996 Jun; 66(6):806-16. PubMed ID: 8647654
[TBL] [Abstract][Full Text] [Related]
8. Human teratocarcinoma stem cells: glycolipid antigen expression and modulation during differentiation.
Andrews PW
J Cell Biochem; 1987 Dec; 35(4):321-32. PubMed ID: 3326883
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical localization of murine stage-specific embryonic antigens in human testicular germ cell tumors.
Damjanov I; Fox N; Knowles BB; Solter D; Lange PH; Fraley EE
Am J Pathol; 1982 Aug; 108(2):225-30. PubMed ID: 6152898
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of glucosylceramide synthase does not reverse drug resistance in cancer cells.
Norris-Cervetto E; Callaghan R; Platt FM; Dwek RA; Butters TD
J Biol Chem; 2004 Sep; 279(39):40412-8. PubMed ID: 15263008
[TBL] [Abstract][Full Text] [Related]
11. [The surface glycolipid antigen specific for the internal cell mass of the mouse blastocyst and of the stem cells of murine teratocarcinoma F9].
Anfimova ML; Bannikov GA; Troianovskiĭ SM
Ontogenez; 1989; 20(2):158-63. PubMed ID: 2472584
[TBL] [Abstract][Full Text] [Related]
12. Regulation of expression of sulfoglucuronyl carbohydrate (HNK-1), Amphoterin and RAGE in retinoic acid-differentiated P19 embryonal carcinoma cells.
Chou DK; Henion TR; Jungalwala FB
J Neurochem; 2003 Aug; 86(4):917-31. PubMed ID: 12887690
[TBL] [Abstract][Full Text] [Related]
13. Effect of an inhibitor of glucosylceramide synthesis on cultured human keratinocytes.
Takami Y; Abe A; Matsuda T; Shayman JA; Radin NS; Walter RJ
J Dermatol; 1998 Feb; 25(2):73-7. PubMed ID: 9563272
[TBL] [Abstract][Full Text] [Related]
14. Human embryonal carcinoma cells and their differentiation in culture.
Andrews PW; Fenderson B; Hakomori S
Int J Androl; 1987 Feb; 10(1):95-104. PubMed ID: 2438234
[TBL] [Abstract][Full Text] [Related]
15. Glycolipids of germ cell tumors: extended globo-series glycolipids are a hallmark of human embryonal carcinoma cells.
Wenk J; Andrews PW; Casper J; Hata J; Pera MF; von Keitz A; Damjanov I; Fenderson BA
Int J Cancer; 1994 Jul; 58(1):108-15. PubMed ID: 8014006
[TBL] [Abstract][Full Text] [Related]
16. Glucosylceramide synthetase inhibitor, D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol exhibits a novel decarcinogenic activity against Shope carcinoma cells.
Kyogashima M; Inoue M; Seto A; Inokuchi J
Cancer Lett; 1996 Mar; 101(1):25-30. PubMed ID: 8625278
[TBL] [Abstract][Full Text] [Related]
17. Abrogation of shedding of immunosuppressive neuroblastoma gangliosides.
Li R; Ladisch S
Cancer Res; 1996 Oct; 56(20):4602-5. PubMed ID: 8840970
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of experimental metastasis of murine Lewis lung carcinoma by an inhibitor of glucosylceramide synthase and its possible mechanism of action.
Inokuchi J; Jimbo M; Momosaki K; Shimeno H; Nagamatsu A; Radin NS
Cancer Res; 1990 Oct; 50(20):6731-7. PubMed ID: 2145065
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the expression of membrane-bound CD54 (mCD54) and soluble form of CD54 (sCD54) in endothelial cells by glucosyl transferase inhibitor: possible role of ceramide for the shedding of mCD54.
Kawakami A; Hida A; Yamasaki S; Miyashita T; Nakashima K; Tanaka F; Ida H; Furuyama M; Migita K; Origuchi T; Eguchi K
Biochem Biophys Res Commun; 2002 Aug; 296(1):26-31. PubMed ID: 12147222
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of [(3)H]thymidine transport is a nonspecific effect of PDMP in primary cultures of mouse epidermal keratinocytes.
Griner RD; Bollag WB
J Pharmacol Exp Ther; 2000 Sep; 294(3):1219-24. PubMed ID: 10945880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]